Trend-spotter: The rise of slow-energy
17-May-2013 - There are two speeds when it comes to energy products: Slow and fast, says Mintel trend-spotting guru David Jago.
More FDA warning letters for website claims and cGMP violations
16-May-2013 - The US Food and Drug Administration has issued warning letters to two dietary supplement companies, as the agency maintains its vigilance of website claims and cGMP compliance.
Special focus: Recent FDA warning letters offer important lessons for companies
15-May-2013 - The US Food and Drug Administration has issued some important warning letters in recent weeks. In this special focus, we revisit the lessons for all companies, from website claims, to the obligations of private label distributors.
Website content an extension of labeling: FDA warning letter shows companies need to ‘think about their real estate space’
09-May-2013 - The FDA has issued a warning letter for a company website that links to articles with disease claims cause products to be drugs (FDA), causing the products linked to such articles to be drugs.
CSPI to Bayer: Fix your One A Day claims or we’ll start a lawsuit
06-May-2013 - The Center for Science in the Public Interest (CSPI) is threatening litigation against Bayer for alleged “deceptive practices in the marketing and sale of several lines of Bayer multivitamins”.
New research bolsters stress-fighting credentials of Relora ingredient
03-May-2013 - Next Pharmaceuticals has bolstered the stress-reducing credentials of its Relora branded ingredient with new research presented at the recent Experimental Biology conference in Boston.
Boxer, DeFazio introduce federal GMO labeling bill
25-Apr-2013 - A bill requiring the labeling of GMO ingredients has been introduced at the federal level by Sen. Barbara Boxer, D-CA and Rep. Peter DeFazio, D-OR. Even though the bill’s chances of passage are uncertain, observers see it as a watershed moment.
Superfruits category still booming (but care is needed)
18-Apr-2013 - Are consumers experiencing superfruit fatigue? Depends on the fruit…and who you talk to.
Research elucidates different approaches to modern ashwagandha ingredients
15-Apr-2013 - Ashwagandha, sometimes called the “king” of ayurvedic herbs, has been gaining traction in the North American marketplace. A big part of the reason is the investments in clinical science and the marketing support made by major suppliers of the ingredient, suppliers who have pursued divergent product development strategies.
New management team to reinvigorate UAS Labs brands, R&D as part of acquisition
15-Apr-2013 - Lakeview Equity Partners, a Milwaukee-based investment firm, has taken its first dip into the human nutrition pool with the acquisition of probiotics supplier and finished goods manufacturer UAS Labs.
Be careful what you 'like'... The FDA is looking at your Facebook page
04-Apr-2013 - Two recent warning letters from the FDA should serve as a reminder to supplement makers that the agency is scrutinizing their activities on Facebook and Twitter just as carefully as it is looking at their corporate websites, say attorneys.
Pterostilbene and ergothioneine: A rich man-poor man story of antioxidant marketing
15-Mar-2013 - With antioxidants that are relatively new to the market, strong scientific evidence backing benefits and modes of action is crucial to constructing a coherent ingredient story, experts say. The tale of two antioxidants, ergothioneine and pterostilbene, illustrates the point.
Award-winning Swedish spinach extract eyeing EU health claim wins
12-Mar-2013 - Swedish firm Greenleaf Medical took the Best New Ingredient gong at the recent NutrAward presented at ExpoWest in Los Angeles for its weight management-focused, spinach extract Appethyl. Now it wants EU health claim victories.
Noncompliant use of testimonials remains durable feature of supplements business
19-Feb-2013 - Regulations regarding how dietary supplement manufacturers can use testimonials to market their products have been on the books for many years now. But judging from recent warning letters and enforcement actions, many companies still aren’t getting the message.
UK venture capitalists eye expansion at Israeli antioxidant specialists
18-Feb-2013 - Southern Israel-based algae-sourced astanxanthin specialists Algatechnologies has won investment from a UK venture capitalist in a move that will broaden its capacity, R&D and distribution scope for the eye and skin health carotenoid.
FDA seizes supplements over sibutramine tainting, disease claims
16-Feb-2013 - FDA seized tainted dietary supplement products from a Florida company called Globe All Wellness, the agency said Friday.
FDA sends more GMP-related warning letters to four dietary supplement manufacturers
14-Feb-2013 - Four dietary supplements have received independent warning letters from the Food and Drug Administration for alleged GMP violations, as the agency maintains its focus on compliance.
Dangerous drug-laced ‘Brazilian slimming coffee’ brand still sold in US
07-Feb-2013 - Despite a Food and Drug Administration (FDA) warning that a sibutramine-laced ‘Brazilian Slimming Coffee’ may pose a 'significant risk' to some US consumers, the product is still widely available online.
Formula-specific science helps product gain entry to practitioner channel
04-Feb-2013 - Emerson Ecologics, which markets a wide range of dietary supplements in the health practitioner channel, has taken on a new cognitive support product, Perceptiv by Sevo Nutraceuticals, attracted, a Sevo official says, by the product’s long list of formula-specific human clinical trials.
Food for Health International hit with FDA warning letter for alleged disease claims, GMP violations
22-Jan-2013 - Utah-based Food for Health International, LLC, has received a warning letter from the Food and Drug Administration (FDA) for alleged disease claims and GMP violations.